VolitionRx Ltd
VNRX
27 hedge funds and large institutions have $11.2M invested in VolitionRx Ltd in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 3 closing their positions.
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
23% more funds holding
Funds holding: 22 → 27 (+5)
6% more capital invested
Capital invested by funds: $10.5M → $11.2M (+$677K)
0.02% more ownership
Funds ownership: 0.95% → 0.97% (+0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Lagoda Investment Management
New York
|
+$993K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$45.8K |
| 3 |
Millennium Management
New York
|
+$40.7K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$32.8K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$19.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$347K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$30.4K |
| 3 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$27.6K |
| 4 |
SBCM
Silverberg Bernstein Capital Management
Armonk,
New York
|
-$5.84K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$5.67K |
VNRX Hedge Fund Activity: Q4 2024 in Review
27 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q4 2024, worth a combined $11.2M — up 6.4% from $10.5M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new VNRX positions and 3 closed out — a net gain of 5 holders — while 7 added to existing stakes and 5 trimmed.
The largest buyer was Lagoda Investment Management, adding an estimated $993K. The largest seller was Armistice Capital, cutting an estimated $347K.
- 27 institutional investors held VolitionRx Ltd (VNRX) as of Q4 2024, up from 22 in Q3 2024.
- Funds reported $11.2M of VolitionRx Ltd stock for Q4 2024, up 6.4% quarter-over-quarter.
- 8 funds opened new VolitionRx Ltd positions in Q4 2024 and 3 closed out, a net change of +5 holders.
- The largest VolitionRx Ltd buyer in Q4 2024 was Lagoda Investment Management, an estimated $993K added.
- The largest VolitionRx Ltd seller in Q4 2024 was Armistice Capital, an estimated $347K sold.
Based on aggregated 13F filings for Q4 2024.